Butyric Acid

Butyric Acid

SCHEMBL507693

CCCC(=O)[O-].CCCCn1cc[n+](C)c1

nearest known ligand 0.70

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.59
HSP90AA1 P07900 2/20 0.59
KMT2A Q03164 2/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
APAF1 O14727 1/20 0.59
NPC1 O15118 1/20 0.59
PLA2G1B P04054 1/20 0.59
MAPT P10636 1/20 0.59
MAPK1 P28482 1/20 0.59
HTT P42858 1/20 0.59
RAB9A P51151 1/20 0.59
NPSR1 Q6W5P4 1/20 0.59
ATG4B Q9Y4P1 1/20 0.59
FFAR3 O14843 2/20 0.42
HDAC3 O15379 2/20 0.42
HDAC1 Q13547 2/20 0.42
HDAC2 Q92769 2/20 0.42
HDAC8 Q9BY41 2/20 0.42
FDPS P14324 11/20 0.42
CA1 P00915 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Succinic Acid SCHEMBL18575092 0.95 MEN1 (0.61) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Butyric Acid SCHEMBL28785416 0.94 MEN1 (0.69) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Valeric Acid SCHEMBL446967 0.94 MEN1 (0.59) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Hexanoate SCHEMBL19406560 0.93 MEN1 (0.62) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Dodecanoate SCHEMBL31549880 0.91 MEN1 (0.65) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Octanoic Acid SCHEMBL3125481 0.91 MEN1 (0.65) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Propionic Acid SCHEMBL358644 0.91 MEN1 (0.63) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Glycolic Acid SCHEMBL18575076 0.91 MEN1 (0.63) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Bicarbonate SCHEMBL5032085 0.91 SMN1; SMN2 (0.67) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1
Levulinic Acid SCHEMBL357674 0.90 MEN1 (0.55) MEN1HSP90AA1KMT2ASMN1; SMN2APAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12421350-B2 Process of preparing a poly(anthranilide), poly(anthranilide) and its use COVESTRO DEUTSCHLAND AG (DE) 2025-09-23 US claimed
US-20230257523-A1 METHOD FOR PRODUCING A POLY(ANTHRANILAMIDE), POLY(ANTHRANILAMIDE) AND USE THEREOF COVESTRO DEUTSCHLAND AG (DE) 2023-08-17 US claimed
US-20230235120-A1 PROCESS OF PREPARING A POLY(ANTHRANILIDE), POLY(ANTHRANILIDE) AND ITS USE COVESTRO DEUTSCHLAND AG (DE) 2023-07-27 US claimed
EP-4179005-A1 PROCESS OF PREPARING A POLY(ANTHRANILAMIDE), POLY(ANTHRANILAMIDE) AND ITS USE Covestro Deutschland AG (DE) 2023-05-17 EP claimed
EP-4179004-A1 METHOD FOR PRODUCING A POLY(ANTHRANILAMIDE), POLY(ANTHRANILAMIDE) AND USE THEREOF Covestro Deutschland AG (DE) 2023-05-17 EP claimed
CN-115996969-A Method for producing poly (anthranilamide), poly (anthranilamide) and use thereof 科思创德国股份有限公司 2023-04-21 CN claimed
CN-115768815-A Method for producing poly (anthranilamides), poly (anthranilamides) and use thereof 科思创德国股份有限公司 2023-03-07 CN claimed
CN-109988449-A A method of preparing titanium dioxide/cenosphere complex reflex thermal insulating filling 中国石油化工股份有限公司 2019-07-09 CN claimed
CN-103193964-B A kind of preparation method of cellulose ester grafted aliphatic polyester multipolymer INSTITUTE OF CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) 2015-08-19 CN claimed
CN-102936762-B Preparation method of chitosan/cellulose homogeneous spinning solution CHINA TEXTILE ACADEMY 2015-04-08 CN claimed
US-7919631-B2 Production of ionic liquids EASTMAN CHEMICAL COMPANY (US) 2011-04-05 US claimed
EP-2121766-A1 CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS Eastman Chemical Company (US) 2009-11-25 EP claimed
EP-2118143-A1 REFORMATION OF IONIC LIQUIDS Eastman Chemical Company (US) 2009-11-18 EP claimed
EP-2118070-A1 PRODUCTION OF IONIC LIQUIDS Eastman Chemical Company (US) 2009-11-18 EP claimed
WO-2008100566-A1 CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS EASTMAN CHEMICAL COMPANY (US) 2008-08-21 WO claimed
WO-2008100577-A1 PRODUCTION OF IONIC LIQUIDS EASTMAN CHEMICAL COMPANY (US) 2008-08-21 WO claimed
WO-2008100569-A1 REFORMATION OF IONIC LIQUIDS EASTMAN CHEMICAL COMPANY (US) 2008-08-21 WO claimed
US-20080194834-A1 PRODUCTION OF IONIC LIQUIDS EASTMAN CHEMICAL COMPANY (US) 2008-08-14 US claimed
US-20080194808-A1 CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS EASTMAN CHEMICAL COMPANY (US) 2008-08-14 US claimed
US-20080194807-A1 REFORMATION OF IONIC LIQUIDS EASTMAN CHEMICAL COMPANY (US) 2008-08-14 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194834-A1 PRODUCTION OF IONIC LIQUIDS GLUL, ICMT, ALAD MEN1 3148/4885HSP90AA1 2703/4885KMT2A 2977/4885
US-20080194808-A1 CELLULOSE ESTERS AND THEIR PRODUCTION IN CARBOXYLATED IONIC LIQUIDS CEL, ACMSD, ACOT7 MEN1 3042/4885HSP90AA1 4487/4885KMT2A 2896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.